PF-06454589
PF-06454589 is a highly effective small molecule LRRK2 kinase inhibitor. It is a valuable research tool for studying Parkinson's disease mechanisms in both cellular (in vitro) and animal (in vivo) models, aiding in the investigation of LRRK2's role in neurobiology.
Product Specifications
CAS Number
1527473-30-8
Product Name Alternative
PF 06454589, PF06454589, PF-06454589, Inhibitor, Leucine-rich repeat kinase 2, G2019S LRRK2, inhibit, LRRK2, parkinson's disease
Field of Research
Cell Biology
Purity
96.29% (May vary between batches)
Solubility
DMSO:9 mg/mL (31.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (3.52 mM)
Smiles
Cn1cc (cn1) -c1c[nH]c2ncnc (N3CCOCC3) c12
Molecular Formula
C14H16N6O
Molecular Weight
284.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A01109-HRP 100 µg/Vial
Anti-Leucyl tRNA synthetase /LARS Antibody Picoband®, HRP Conjugate
Sign In for Pricing
View Details OR1056752-01 100 mg
(R) -tert-Butyl (6-methoxy-2,3-dihydrobenzofuran-3-yl) carbamate
Sign In for Pricing
View Details OR1056752-02 250 mg
(R) -tert-Butyl (6-methoxy-2,3-dihydrobenzofuran-3-yl) carbamate
Sign In for Pricing
View Details OR1056752-03 1 g
(R) -tert-Butyl (6-methoxy-2,3-dihydrobenzofuran-3-yl) carbamate
Sign In for Pricing
View Details 